{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2007-D-0369\" and posted_year = 2024 sorted by posted_date descending", "rows": [["FDA-2007-D-0369-2066", "FDA", "FDA-2007-D-0369", "PSG_216993 - Draft Guidance on Quizartinib Dihydrochloride", "Other", "Guidance", "2024-11-21T05:00:00Z", 2024, 11, "2024-11-21T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:34:51Z", null, 1, 0, "09000064868293cc"], ["FDA-2007-D-0369-2018", "FDA", "FDA-2007-D-0369", "PSG_020833 - Draft Guidance on Fluticasone Propionate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2025-01-17T02:01:11Z", null, 1, 0, "0900006486829349"], ["FDA-2007-D-0369-2060", "FDA", "FDA-2007-D-0369", "PSG_216632 - Draft Guidance on Adapalene; Benzoyl Peroxide; Clindamycin Phosphate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-12-11T02:01:02Z", null, 1, 0, "09000064868293ca"], ["FDA-2007-D-0369-2012", "FDA", "FDA-2007-D-0369", "PSG_017533-Sus - Draft Guidance on Clonazepam", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T19:55:15Z", null, 1, 0, "0900006486829330"], ["FDA-2007-D-0369-2013", "FDA", "FDA-2007-D-0369", "PSG_018687 - Draft Guidance on Labetalol Hydrochloride", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T19:59:07Z", null, 1, 0, "0900006486829332"], ["FDA-2007-D-0369-2021", "FDA", "FDA-2007-D-0369", "PSG_021190 - Draft Guidance on Buspirone Hydrochloride", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:08:24Z", null, 1, 0, "0900006486829350"], ["FDA-2007-D-0369-2022", "FDA", "FDA-2007-D-0369", "PSG_021359 - Draft Guidance on Nitroglycerin", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:08:59Z", null, 1, 0, "0900006486829357"], ["FDA-2007-D-0369-2057", "FDA", "FDA-2007-D-0369", "PSG_215830 - Draft Guidance on Ritlecitinib Tosylate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:28:25Z", null, 1, 0, "09000064868293c3"], ["FDA-2007-D-0369-2053", "FDA", "FDA-2007-D-0369", "PSG_215179 - Draft Guidance on Pemetrexed Disodium", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:26:20Z", null, 1, 0, "09000064868293b4"], ["FDA-2007-D-0369-2015", "FDA", "FDA-2007-D-0369", "PSG_020281 - Draft Guidance on Tramadol Hydrochloride", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T20:00:27Z", null, 1, 0, "0900006486829336"], ["FDA-2007-D-0369-2007", "FDA", "FDA-2007-D-0369", "PSG_009170 - Draft Guidance on Primidone", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T19:52:32Z", null, 1, 0, "0900006486829323"], ["FDA-2007-D-0369-2006", "FDA", "FDA-2007-D-0369", "Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability", "Notice", "Notice of Availability", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", null, "2024-11-21T19:50:01Z", "2024-27048", 0, 0, "0900006486829e19"], ["FDA-2007-D-0369-2027", "FDA", "FDA-2007-D-0369", "PSG_021641 - Draft Guidance on Rasagiline Mesylate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:11:57Z", null, 1, 0, "0900006486829361"], ["FDA-2007-D-0369-2026", "FDA", "FDA-2007-D-0369", "PSG_021487-ODT - Draft Guidance on Memantine Hydrochloride", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:11:26Z", null, 1, 0, "090000648682935f"], ["FDA-2007-D-0369-2038", "FDA", "FDA-2007-D-0369", "PSG_087954 - Draft Guidance on Phytonadione", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:18:05Z", null, 1, 0, "0900006486829381"], ["FDA-2007-D-0369-2040", "FDA", "FDA-2007-D-0369", "PSG_203491 - Draft Guidance on Nepafenac", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:19:09Z", null, 1, 0, "0900006486829385"], ["FDA-2007-D-0369-2056", "FDA", "FDA-2007-D-0369", "PSG_215559 - Draft Guidance on Palovarotene", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:27:51Z", null, 1, 0, "09000064868293c1"], ["FDA-2007-D-0369-2051", "FDA", "FDA-2007-D-0369", "PSG_213674 - Draft Guidance on Enzalutamide", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:25:08Z", null, 1, 0, "09000064868293a6"], ["FDA-2007-D-0369-2064", "FDA", "FDA-2007-D-0369", "PSG_217469 - Draft Guidance on Cyclosporine", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:33:49Z", null, 1, 0, "09000064868293de"], ["FDA-2007-D-0369-2050", "FDA", "FDA-2007-D-0369", "PSG_213586 - Draft Guidance on Risperidone", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:24:37Z", null, 1, 0, "09000064868293a4"], ["FDA-2007-D-0369-2010", "FDA", "FDA-2007-D-0369", "PSG_016084 - Draft Guidance on Allopurinol", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T19:54:11Z", null, 1, 0, "0900006486829329"], ["FDA-2007-D-0369-2020", "FDA", "FDA-2007-D-0369", "PSG_021184-Cre-0.05P - Draft Guidance on Tazarotene", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:07:46Z", null, 1, 0, "090000648682934e"], ["FDA-2007-D-0369-2024", "FDA", "FDA-2007-D-0369", "PSG_021470 - Draft Guidance on Azelaic Acid", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:10:13Z", null, 1, 0, "090000648682935b"], ["FDA-2007-D-0369-2033", "FDA", "FDA-2007-D-0369", "PSG_022341 - Draft Guidance on Liraglutide", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:15:06Z", null, 1, 0, "0900006486829376"], ["FDA-2007-D-0369-2014", "FDA", "FDA-2007-D-0369", "PSG_020216 - Draft Guidance on Estrogens, Conjugated", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2025-09-15T09:00:17Z", null, 1, 0, "0900006486829334"], ["FDA-2007-D-0369-2048", "FDA", "FDA-2007-D-0369", "PSG_211728 - Draft Guidance on Mitomycin", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2025-03-06T02:00:19Z", null, 1, 0, "09000064868293a0"], ["FDA-2007-D-0369-2042", "FDA", "FDA-2007-D-0369", "PSG_205641 - Draft Guidance on Mometasone Furoate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2025-01-17T02:01:11Z", null, 1, 0, "0900006486829389"], ["FDA-2007-D-0369-2016", "FDA", "FDA-2007-D-0369", "PSG_020692 - Draft Guidance on Salmeterol Xinafoate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2025-01-17T02:01:10Z", null, 1, 0, "0900006486829345"], ["FDA-2007-D-0369-2023", "FDA", "FDA-2007-D-0369", "PSG_021395 - Draft Guidance on Tiotropium Bromide", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2025-01-17T02:00:59Z", null, 1, 0, "0900006486829359"], ["FDA-2007-D-0369-2049", "FDA", "FDA-2007-D-0369", "PSG_212905 - Draft Guidance on Cantharidin", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:24:04Z", null, 1, 0, "09000064868293a2"], ["FDA-2007-D-0369-2058", "FDA", "FDA-2007-D-0369", "PSG_216338 - Draft Guidance on Paclitaxel", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:28:54Z", null, 1, 0, "09000064868293c5"], ["FDA-2007-D-0369-2039", "FDA", "FDA-2007-D-0369", "PSG_203159 - Draft Guidance on Levonorgestrel", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:18:39Z", null, 1, 0, "0900006486829383"], ["FDA-2007-D-0369-2046", "FDA", "FDA-2007-D-0369", "PSG_210251 - Draft Guidance on Bictegravir Sodium; Emtricitabine; Tenofovir Alafenamide Fumarate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:22:28Z", null, 1, 0, "090000648682939c"], ["FDA-2007-D-0369-2059", "FDA", "FDA-2007-D-0369", "PSG_216387 - Draft Guidance on Acalabrutinib Maleate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:29:28Z", null, 1, 0, "09000064868293c7"], ["FDA-2007-D-0369-2035", "FDA", "FDA-2007-D-0369", "PSG_050065 - Draft Guidance on Dexamethasone; Neomycin Sulfate; Polymyxin B Sulfate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:16:09Z", null, 1, 0, "090000648682937a"], ["FDA-2007-D-0369-2061", "FDA", "FDA-2007-D-0369", "PSG_217006 - Draft Guidance on Aripiprazole", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:32:15Z", null, 1, 0, "09000064868293ce"], ["FDA-2007-D-0369-2063", "FDA", "FDA-2007-D-0369", "PSG_217388 - Draft Guidance on Eplontersen Sodium", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:33:17Z", null, 1, 0, "09000064868293d2"], ["FDA-2007-D-0369-2025", "FDA", "FDA-2007-D-0369", "PSG_021481 - Draft Guidance on Enfuvirtide", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:10:50Z", null, 1, 0, "090000648682935d"], ["FDA-2007-D-0369-2041", "FDA", "FDA-2007-D-0369", "PSG_203565 - Draft Guidance on Ferric Carboxymaltose", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2025-06-05T09:00:09Z", null, 1, 0, "0900006486829387"], ["FDA-2007-D-0369-2055", "FDA", "FDA-2007-D-0369", "PSG_215344 - Draft Guidance on Magnesium Sulfate; Polyethylene Glycol 3350; Potassium Chloride; Sodium Chloride; Sodium Sulfate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:27:21Z", null, 1, 0, "09000064868293bf"], ["FDA-2007-D-0369-2036", "FDA", "FDA-2007-D-0369", "PSG_050777 - Draft Guidance on Tacrolimus", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:16:54Z", null, 1, 0, "090000648682937c"], ["FDA-2007-D-0369-2037", "FDA", "FDA-2007-D-0369", "PSG_083722 - Draft Guidance on Phytonadione", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:17:26Z", null, 1, 0, "090000648682937e"], ["FDA-2007-D-0369-2054", "FDA", "FDA-2007-D-0369", "PSG_215309 - Draft Guidance on Ruxolitinib Phosphate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:26:49Z", null, 1, 0, "09000064868293b6"], ["FDA-2007-D-0369-2009", "FDA", "FDA-2007-D-0369", "PSG_011745 - Draft Guidance on Phytonadione", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T19:53:37Z", null, 1, 0, "0900006486829327"], ["FDA-2007-D-0369-2011", "FDA", "FDA-2007-D-0369", "PSG_016084-Sus - Draft Guidance on Allopurinol", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T19:54:42Z", null, 1, 0, "090000648682932e"], ["FDA-2007-D-0369-2028", "FDA", "FDA-2007-D-0369", "PSG_021862 - Draft Guidance on Nepafenac", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:12:29Z", null, 1, 0, "0900006486829363"], ["FDA-2007-D-0369-2065", "FDA", "FDA-2007-D-0369", "PSG_218490 - Draft Guidance on Macitentan; Tadalafil", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:34:21Z", null, 1, 0, "09000064868293e0"], ["FDA-2007-D-0369-2044", "FDA", "FDA-2007-D-0369", "PSG_208558 - Draft Guidance on Olaparib", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:21:24Z", null, 1, 0, "0900006486829398"], ["FDA-2007-D-0369-2034", "FDA", "FDA-2007-D-0369", "PSG_022518 - Draft Guidance on Formoterol Fumarate; Mometasone Furoate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2025-01-17T02:01:10Z", null, 1, 0, "0900006486829378"], ["FDA-2007-D-0369-2031", "FDA", "FDA-2007-D-0369", "PSG_022150 - Draft Guidance on Icatibant Acetate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:14:05Z", null, 1, 0, "0900006486829367"], ["FDA-2007-D-0369-2032", "FDA", "FDA-2007-D-0369", "PSG_022180 - Draft Guidance on Ferumoxytol", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:14:36Z", null, 1, 0, "0900006486829369"], ["FDA-2007-D-0369-2030", "FDA", "FDA-2007-D-0369", "PSG_020386 - Draft Guidance on Losartan Potassium", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:13:34Z", null, 1, 0, "0900006486829343"], ["FDA-2007-D-0369-2047", "FDA", "FDA-2007-D-0369", "PSG_211413 - Draft Guidance on Cefazolin Sodium", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:23:01Z", null, 1, 0, "090000648682939e"], ["FDA-2007-D-0369-2043", "FDA", "FDA-2007-D-0369", "PSG_206947 - Draft Guidance on Lenvatinib Mesylate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:20:49Z", null, 1, 0, "0900006486829396"], ["FDA-2007-D-0369-2008", "FDA", "FDA-2007-D-0369", "PSG_010104 - Draft Guidance on Phytonadione", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T19:53:05Z", null, 1, 0, "0900006486829325"], ["FDA-2007-D-0369-2062", "FDA", "FDA-2007-D-0369", "PSG_217064 - Draft Guidance on Phentolamine Mesylate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2024-11-21T21:32:46Z", null, 1, 0, "09000064868293d0"], ["FDA-2007-D-0369-2017", "FDA", "FDA-2007-D-0369", "PSG_020831 - Draft Guidance on Formoterol Fumarate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2025-01-17T02:01:07Z", null, 1, 0, "0900006486829347"], ["FDA-2007-D-0369-2019", "FDA", "FDA-2007-D-0369", "PSG_021077 - Draft Guidance on Fluticasone Propionate; Salmeterol Xinafoate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2025-01-17T02:01:14Z", null, 1, 0, "090000648682934b"], ["FDA-2007-D-0369-2029", "FDA", "FDA-2007-D-0369", "PSG_021929 - Draft Guidance on Budesonide; Formoterol Fumarate Dihydrate", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2025-01-17T02:01:10Z", null, 1, 0, "0900006486829365"], ["FDA-2007-D-0369-2052", "FDA", "FDA-2007-D-0369", "PSG_214324 - Draft Guidance on Treprostinil", "Other", "Guidance", "2024-11-20T05:00:00Z", 2024, 11, "2024-11-20T05:00:00Z", "2025-01-22T04:59:59Z", "2025-01-17T02:01:14Z", null, 1, 0, "09000064868293a8"], ["FDA-2007-D-0369-2045", "FDA", "FDA-2007-D-0369", "PSG_209830 - Draft Guidance on Aripiprazole Lauroxil", "Other", "Guidance", "2024-11-20T00:00:00Z", 2024, 11, "2024-11-20T00:00:00Z", "2025-01-22T04:59:59Z", "2025-05-09T01:17:15Z", null, 1, 0, "090000648682939a"], ["FDA-2007-D-0369-2004", "FDA", "FDA-2007-D-0369", "PSG_078690 - Draft Guidance on Carbidopa; Levodopa", "Other", "Guidance", "2024-11-14T05:00:00Z", 2024, 11, "2024-11-14T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-14T21:10:46Z", null, 1, 0, "090000648681414e"], ["FDA-2007-D-0369-2003", "FDA", "FDA-2007-D-0369", "PSG_011808 - Draft Guidance on Thioridazine Hydrochloride", "Other", "Guidance", "2024-11-14T05:00:00Z", 2024, 11, "2024-11-14T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-14T21:10:38Z", null, 1, 0, "09000064867f21ca"], ["FDA-2007-D-0369-1995", "FDA", "FDA-2007-D-0369", "PSG_209899 - Draft Guidance on Ozanimod Hydrochloride", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T20:56:51Z", null, 1, 0, "09000064867f2d7d"], ["FDA-2007-D-0369-1954", "FDA", "FDA-2007-D-0369", "PSG_050759 - Draft Guidance on Mycophenolate Mofetil", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T12:54:37Z", null, 1, 0, "09000064867f240b"], ["FDA-2007-D-0369-1972", "FDA", "FDA-2007-D-0369", "PSG_083976 - Draft Guidance on Methyltestosterone", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T12:54:47Z", null, 1, 0, "09000064867f242f"], ["FDA-2007-D-0369-1981", "FDA", "FDA-2007-D-0369", "PSG_200175 - Draft Guidance on Amlodipine Besylate; Hydrochlorothiazide; Olmesartan Medoxomil", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T12:54:53Z", null, 1, 0, "09000064867f2441"], ["FDA-2007-D-0369-1983", "FDA", "FDA-2007-D-0369", "PSG_201280 - Draft Guidance on Linagliptin", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T12:54:54Z", null, 1, 0, "09000064867f2445"], ["FDA-2007-D-0369-1953", "FDA", "FDA-2007-D-0369", "PSG_050725 - Draft Guidance on Amoxicillin; Clavulanate Potassium", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T12:54:36Z", null, 1, 0, "09000064867f2409"], ["FDA-2007-D-0369-1986", "FDA", "FDA-2007-D-0369", "PSG_201373 - Draft Guidance on Fexofenadine Hydrochloride", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T12:54:56Z", null, 1, 0, "09000064867f244b"], ["FDA-2007-D-0369-1957", "FDA", "FDA-2007-D-0369", "PSG_050722 - Draft Guidance on Mycophenolate Mofetil", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T12:54:38Z", null, 1, 0, "09000064867f2411"], ["FDA-2007-D-0369-1975", "FDA", "FDA-2007-D-0369", "PSG_200534 - Draft Guidance on Oxycodone Hydrochloride", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T12:54:49Z", null, 1, 0, "09000064867f2435"], ["FDA-2007-D-0369-1889", "FDA", "FDA-2007-D-0369", "PSG_022344 - Draft Guidance on Lamivudine; Tenofovir Disoproxil Fumara", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:44:53Z", null, 1, 0, "09000064867f237f"], ["FDA-2007-D-0369-1941", "FDA", "FDA-2007-D-0369", "PSG_050542 - Draft Guidance on Amoxicillin", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:11Z", null, 1, 0, "09000064867f23f1"], ["FDA-2007-D-0369-1938", "FDA", "FDA-2007-D-0369", "PSG_050662 - Draft Guidance on Clarithromycin", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:10Z", null, 1, 0, "09000064867f23eb"], ["FDA-2007-D-0369-1893", "FDA", "FDA-2007-D-0369", "PSG_022363 - Draft Guidance on Pitavastatin Calcium", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:44:57Z", null, 1, 0, "09000064867f2391"], ["FDA-2007-D-0369-1936", "FDA", "FDA-2007-D-0369", "PSG_050641-Cap-150MG - Draft Guidance on Doxycycline", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:08Z", null, 1, 0, "09000064867f23e7"], ["FDA-2007-D-0369-1797", "FDA", "FDA-2007-D-0369", "PSG_019915 - Draft Guidance on Fosinopril Sodium", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:25Z", null, 1, 0, "09000064867ee4fa"], ["FDA-2007-D-0369-1817", "FDA", "FDA-2007-D-0369", "PSG_020251 - Draft Guidance on Ranitidine Hydrochloride", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:29Z", null, 1, 0, "09000064867f2123"], ["FDA-2007-D-0369-1822", "FDA", "FDA-2007-D-0369", "PSG_020180 - Draft Guidance on Finasteride", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:32Z", null, 1, 0, "09000064867f212d"], ["FDA-2007-D-0369-1832", "FDA", "FDA-2007-D-0369", "PSG_020264 - Draft Guidance on Megestrol Acetate", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:33Z", null, 1, 0, "09000064867f2141"], ["FDA-2007-D-0369-1836", "FDA", "FDA-2007-D-0369", "PSG_020286 - Draft Guidance on Fosinopril Sodium; Hydrochlorothiazide", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:35Z", null, 1, 0, "09000064867f2149"], ["FDA-2007-D-0369-1839", "FDA", "FDA-2007-D-0369", "PSG_020297 - Draft Guidance on Carvedilol", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:35Z", null, 1, 0, "09000064867f214f"], ["FDA-2007-D-0369-1843", "FDA", "FDA-2007-D-0369", "PSG_020397 - Draft Guidance on Tizanidine Hydrochloride", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:36Z", null, 1, 0, "09000064867f2157"], ["FDA-2007-D-0369-1858", "FDA", "FDA-2007-D-0369", "PSG_020528 - Draft Guidance on Trandolapril", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:39Z", null, 1, 0, "09000064867f2175"], ["FDA-2007-D-0369-1871", "FDA", "FDA-2007-D-0369", "PSG_020702 - Draft Guidance on Atorvastatin Calcium", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:42Z", null, 1, 0, "09000064867f2190"], ["FDA-2007-D-0369-1876", "FDA", "FDA-2007-D-0369", "PSG_020713 - Draft Guidance on Desogestrel; Ethinyl Estradiol", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:45Z", null, 1, 0, "09000064867f219a"], ["FDA-2007-D-0369-1877", "FDA", "FDA-2007-D-0369", "PSG_020717 - Draft Guidance on Modafinil", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:45Z", null, 1, 0, "09000064867f219c"], ["FDA-2007-D-0369-1879", "FDA", "FDA-2007-D-0369", "PSG_020658 - Draft Guidance on Ropinirole Hydrochloride", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:45Z", null, 1, 0, "09000064867f21a0"], ["FDA-2007-D-0369-1882", "FDA", "FDA-2007-D-0369", "PSG_020636 - Draft Guidance on Nevirapine", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:46Z", null, 1, 0, "09000064867f21b0"], ["FDA-2007-D-0369-1884", "FDA", "FDA-2007-D-0369", "PSG_020704 - Draft Guidance on Loratadine", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T22:45:46Z", null, 1, 0, "09000064867f21b4"], ["FDA-2007-D-0369-1944", "FDA", "FDA-2007-D-0369", "PSG_050665 - Draft Guidance on Cefprozil", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-14T13:15:12Z", null, 1, 0, "09000064867f23f7"], ["FDA-2007-D-0369-1991", "FDA", "FDA-2007-D-0369", "PSG_009838 - Draft Guidance on Reserpine", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-13T16:42:38Z", null, 1, 0, "09000064867ee375"], ["FDA-2007-D-0369-1802", "FDA", "FDA-2007-D-0369", "PSG_019906 - Draft Guidance on Clomipramine Hydrochloride", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-13T19:22:23Z", null, 1, 0, "09000064867f2105"], ["FDA-2007-D-0369-1840", "FDA", "FDA-2007-D-0369", "PSG_020448 - Draft Guidance on Loperamide Hydrochloride", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-13T19:29:13Z", null, 1, 0, "09000064867f2151"], ["FDA-2007-D-0369-1883", "FDA", "FDA-2007-D-0369", "PSG_020667 - Draft Guidance on Pramipexole Dihydrochloride", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-13T19:42:00Z", null, 1, 0, "09000064867f21b2"], ["FDA-2007-D-0369-1897", "FDA", "FDA-2007-D-0369", "PSG_022565 - Draft Guidance on Ibuprofen; Phenylephrine Hydrochloride", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2025-11-17T10:00:09Z", null, 1, 0, "09000064867f2399"], ["FDA-2007-D-0369-1965", "FDA", "FDA-2007-D-0369", "PSG_083266 - Draft Guidance on Estrogens, Esterified", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T12:54:43Z", null, 1, 0, "09000064867f2421"], ["FDA-2007-D-0369-1966", "FDA", "FDA-2007-D-0369", "PSG_050749 - Draft Guidance on Cefdinir", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T12:54:44Z", null, 1, 0, "09000064867f2423"], ["FDA-2007-D-0369-1950", "FDA", "FDA-2007-D-0369", "PSG_062279 - Draft Guidance on Griseofulvin, Microcrystalline; Griseofulvin, Microsize", "Other", "Guidance", "2024-11-12T05:00:00Z", 2024, 11, "2024-11-12T05:00:00Z", "2024-12-31T04:59:59Z", "2024-11-12T12:54:35Z", null, 1, 0, "09000064867f2403"]], "truncated": false, "filtered_table_rows_count": 1044, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 and \"posted_year\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA-2007-D-0369", "p1": "2024"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024", "results": [{"value": "FDA", "label": "FDA", "count": 1044, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024", "results": [{"value": "Other", "label": "Other", "count": 1038, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&document_type=Other", "selected": false}, {"value": "Notice", "label": "Notice", "count": 6, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&document_type=Notice", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024", "results": [{"value": 2024, "label": 2024, "count": 1044, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&_facet=comment_start_date"}, {"name": "comment_end_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&_facet=comment_end_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&_facet_date=last_modified"}], "next": "2024-11-12T05~3A00~3A00Z,FDA-2007-D-0369-1950", "next_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2007-D-0369&posted_year=2024&_next=2024-11-12T05~3A00~3A00Z%2CFDA-2007-D-0369-1950&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 1482.9122409573756, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}